4//SEC Filing
SARGEN GREGORY 4
Accession 0001683168-22-008498
CIK 0000704562other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 8:01 PM ET
Size
9.7 KB
Accession
0001683168-22-008498
Insider Transaction Report
Form 4
SARGEN GREGORY
Director
Transactions
- Award
Restricted Stock Units
2022-12-14+9,612→ 9,612 total→ Common Stock (9,612 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2022-12-14+4,632→ 7,011 total - Exercise/Conversion
Restricted Stock Units
2022-12-14−4,632→ 0 total→ Common Stock (4,632 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
- [F2]RSUs granted to the reporting person on December 14, 2021 pursuant to the Issuer's non-employee director compensation program which fully vested on December 14, 2022.
- [F3]Annual equity award grant pursuant to the Issuer's non-employee director compensation program.
- [F4]The RSUs granted to the reported person on December 14, 2022 shall fully vest on December 14, 2023, subject to the reporting person's continuous service to the Issuer on such vesting date.
Documents
Issuer
Avid Bioservices, Inc.
CIK 0000704562
Entity typeother
Related Parties
1- filerCIK 0001227835
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 8:01 PM ET
- Size
- 9.7 KB